Abstract submission is open and you are welcome to submit your research findings until 23 May 2023 for a chance to deliver a Poster presentation at ICLE 2023.

Choose among the topics below when submitting your abstract:

• Update on the approved therapies
• Currently ongoing clinical trials
• Novel clinical approaches and combination therapies
• Superpowered lymphocytes
• Non-viral CAR/TCR engineering
• Universal donor cells & advanced TCR engineering
• Beyond alpha-beta T cells
• In vivo T-cell engineering
• Targeting non-malignant diseases
• Other